Skip to main navigation
Skip to search
Skip to main content
Fox Chase Cancer Center Home
Help & FAQ
Home
Profiles
Research Units
Research Resources
Research Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Progress in the management of melanoma in 2013
Daniel G. Coit
,
Anthony J. Olszanski
Cancer Signaling and Microenvironment (CSM)
Center for Immunology
Hematology Oncology
Memorial Sloan-Kettering Cancer Center
Research output
:
Contribution to journal
›
Review article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Progress in the management of melanoma in 2013'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Nodular Melanoma
100%
Therapeutic Procedure
66%
Disease
66%
Survival
66%
Patient
33%
Oncology
33%
Ipilimumab
33%
Lesion
33%
Immunotherapy
33%
Sentinel Lymph Node Biopsy
33%
Vemurafenib
33%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Diseases
66%
Survival
66%
Immunotherapy
33%
Ipilimumab
33%
Vemurafenib
33%